LPL Financial’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
68,391
+4,200
+7% +$52.5K ﹤0.01% 4248
2026
Q1
$584K Buy
64,191
+6,984
+12% +$88.2K ﹤0.01% 4624
2025
Q4
$783K Buy
57,207
+9,857
+21% +$183K ﹤0.01% 4316
2025
Q3
$1.03M Buy
47,350
+628
+1% +$7.4K ﹤0.01% 3974
2025
Q2
$558K Buy
46,722
+4,972
+12% +$62.6K ﹤0.01% 4285
2025
Q1
$496K Buy
41,750
+1,500
+4% +$23.3K ﹤0.01% 4183
2024
Q4
$619K Buy
40,250
+1,750
+5% +$22.7K ﹤0.01% 3903
2024
Q3
$432K Sell
38,500
-1,000
-3% -$9.58K ﹤0.01% 4123
2024
Q2
$213K Buy
39,500
+750
+2% +$4.34K ﹤0.01% 4520
2024
Q1
$264K Buy
38,750
+6,300
+19% +$44K ﹤0.01% 4305
2023
Q4
$220K Buy
32,450
+1,000
+3% +$5.66K ﹤0.01% 4324
2023
Q3
$158K Buy
31,450
+2,000
+7% +$11.9K ﹤0.01% 4314
2023
Q2
$213K Buy
29,450
+2,925
+11% +$24.9K ﹤0.01% 4106
2023
Q1
$224K Sell
26,525
-100
-0.4% -$876 ﹤0.01% 3956
2022
Q4
$226K Sell
26,625
-7,000
-21% -$66.3K ﹤0.01% 3892
2022
Q3
$348K Buy
33,625
+1,775
+6% +$23.4K ﹤0.01% 3453
2022
Q2
$416K Buy
31,850
+5,325
+20% +$54.4K ﹤0.01% 3362
2022
Q1
$276K Buy
26,525
+5,750
+28% +$52.3K ﹤0.01% 3625
2021
Q4
$233K Buy
20,775
+10,450
+101% +$156K ﹤0.01% 3879
2021
Q3
$183K Buy
10,325
+300
+3% +$5.63K ﹤0.01% 4013
2021
Q2
$191K Buy
+10,025
New +$194K ﹤0.01% 3913

Other funds holding CLPT

LPL Financial's CLPT Position: Q2 2026 in Review

LPL Financial increased its ClearPoint Neuro (CLPT) stake by 6.5% in Q2 2026, buying an estimated $52.5K and bringing the position to 68,391 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #4248.

LPL Financial first reported a position in CLPT in Q2 2021 and has held it in 21 quarters since. 45 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • LPL Financial held 68,391 shares of ClearPoint Neuro worth $1.22M as of Q2 2026.
  • LPL Financial bought 4,200 ClearPoint Neuro shares in Q2 2026, an estimated $52.5K.
  • ClearPoint Neuro made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4248 holding.
  • LPL Financial first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 21 quarters since.
  • 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.